Search

Search Constraints

You searched for: Author/Creator Langston, Amelia A.

Search Results

1. A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma. (7th August 2015)

2. A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Issue 1 (25th May 2012)

5. Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?. Issue 13 (27th February 2017)

6. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Issue 21 (6th August 2013)

7. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Issue 21 (6th August 2013)

8. Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Issue 6 (10th December 2019)

10. Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Issue 20 (24th July 2015)